Joanne Wuensch
Stock Analyst at Citi
(1.99)
# 3,160
Out of 4,455 analysts
1174
Total ratings
50.7%
Success rate
0.1%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintained: Buy | $108 → $89 | $93.24 | -4.55% | 83 | Jun 17, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | $101 | $89.72 | +12.57% | 79 | Jun 15, 2026 | |
| GKOS Glaukos | Maintained: Buy | $140 → $162 | $142.57 | +13.63% | 42 | Jun 12, 2026 | |
| MDT Medtronic | Maintained: Buy | $110 | $80.52 | +36.61% | 80 | Jun 3, 2026 | |
| MMED MiniMed Group | Maintained: Buy | $23 | $14.22 | +61.74% | 3 | Jun 3, 2026 | |
| BAX Baxter International | Downgraded: Hold | $19 → $17 | $21.55 | -21.11% | 58 | May 29, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $87 → $70 | $44.20 | +58.37% | 75 | May 29, 2026 | |
| DXCM DexCom | Maintained: Buy | $79 → $84 | $68.65 | +22.36% | 62 | May 29, 2026 | |
| ITGR Integer Holdings | Maintained: Hold | $89 → $92 | $93.12 | -1.20% | 18 | May 29, 2026 | |
| HAE Haemonetics | Maintained: Hold | $64 → $70 | $77.62 | -9.82% | 26 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $175 → $165 | $153.82 | +7.27% | 42 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $95 → $93 | $90.96 | +2.24% | 60 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $17 | $15.76 | +7.87% | 43 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.35 → $5.15 | $5.45 | -5.42% | 26 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $80 → $69 | $70.64 | -2.32% | 54 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $11 → $16 | $18.10 | -11.60% | 28 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $590 | $399.69 | +47.61% | 32 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $385 | $316.11 | +21.79% | 56 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $374 → $350 | $317.40 | +10.27% | 42 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $65 → $76 | $89.07 | -14.67% | 20 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 → $157 | $115.99 | +35.36% | 56 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $19 | $15.91 | +19.42% | 16 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $80 → $65 | $64.94 | +0.09% | 24 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $285 | $244.88 | +16.38% | 59 | Apr 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $198 | $151.38 | +30.80% | 37 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.15 | $1.25 | n/a | 17 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 54.31 → CHF 55.93 | $55.74 | n/a | 11 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $124 → $120 | $198.60 | n/a | 23 | Jan 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $23.67 | n/a | 2 | Sep 26, 2016 |
Abbott Laboratories
Jun 17, 2026
Maintained: Buy
Price Target: $108 → $89
Current: $93.24
Upside: -4.55%
Edwards Lifesciences
Jun 15, 2026
Maintained: Buy
Price Target: $101
Current: $89.72
Upside: +12.57%
Glaukos
Jun 12, 2026
Maintained: Buy
Price Target: $140 → $162
Current: $142.57
Upside: +13.63%
Medtronic
Jun 3, 2026
Maintained: Buy
Price Target: $110
Current: $80.52
Upside: +36.61%
MiniMed Group
Jun 3, 2026
Maintained: Buy
Price Target: $23
Current: $14.22
Upside: +61.74%
Baxter International
May 29, 2026
Downgraded: Hold
Price Target: $19 → $17
Current: $21.55
Upside: -21.11%
Boston Scientific
May 29, 2026
Maintained: Buy
Price Target: $87 → $70
Current: $44.20
Upside: +58.37%
DexCom
May 29, 2026
Maintained: Buy
Price Target: $79 → $84
Current: $68.65
Upside: +22.36%
Integer Holdings
May 29, 2026
Maintained: Hold
Price Target: $89 → $92
Current: $93.12
Upside: -1.20%
Haemonetics
May 29, 2026
Maintained: Hold
Price Target: $64 → $70
Current: $77.62
Upside: -9.82%
May 29, 2026
Maintained: Hold
Price Target: $175 → $165
Current: $153.82
Upside: +7.27%
May 29, 2026
Maintained: Hold
Price Target: $95 → $93
Current: $90.96
Upside: +2.24%
May 29, 2026
Maintained: Hold
Price Target: $22 → $17
Current: $15.76
Upside: +7.87%
May 29, 2026
Maintained: Hold
Price Target: $4.35 → $5.15
Current: $5.45
Upside: -5.42%
May 28, 2026
Maintained: Hold
Price Target: $80 → $69
Current: $70.64
Upside: -2.32%
May 28, 2026
Upgraded: Hold
Price Target: $11 → $16
Current: $18.10
Upside: -11.60%
May 28, 2026
Reiterated: Buy
Price Target: $590
Current: $399.69
Upside: +47.61%
May 28, 2026
Reiterated: Buy
Price Target: $385
Current: $316.11
Upside: +21.79%
May 7, 2026
Maintained: Hold
Price Target: $374 → $350
Current: $317.40
Upside: +10.27%
May 6, 2026
Rated: Hold
Price Target: $65 → $76
Current: $89.07
Upside: -14.67%
May 4, 2026
Rated: Buy
Price Target: $155 → $157
Current: $115.99
Upside: +35.36%
Apr 30, 2026
Maintained: Buy
Price Target: $21 → $19
Current: $15.91
Upside: +19.42%
Apr 30, 2026
Maintained: Hold
Price Target: $80 → $65
Current: $64.94
Upside: +0.09%
Apr 26, 2026
Reiterated: Buy
Price Target: $285
Current: $244.88
Upside: +16.38%
Apr 7, 2026
Maintained: Buy
Price Target: $198
Current: $151.38
Upside: +30.80%
May 23, 2025
Maintained: Hold
Price Target: $4.15
Current: $1.25
Upside: n/a
Nov 16, 2022
Maintained: Hold
Price Target: CHF 54.31 → CHF 55.93
Current: $55.74
Upside: n/a
Jan 27, 2019
Reiterated: Buy
Price Target: $124 → $120
Current: $198.60
Upside: n/a
Sep 26, 2016
Reiterated: Buy
Price Target: $40
Current: $23.67
Upside: n/a